Jason S. Chapman, Ph.D. - Publications
Affiliations: | 2004 | University of Wisconsin, Madison, Madison, WI |
Area:
Biochemistry, OncologyYear | Citation | Score | |||
---|---|---|---|---|---|
2007 | Anding AL, Chapman JS, Barnett DW, Curley RW, Clagett-Dame M. The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor. Cancer Research. 67: 6270-7. PMID 17616685 DOI: 10.1158/0008-5472.Can-07-0727 | 0.574 | |||
2007 | Mershon SM, Anding AL, Chapman JS, Clagett-Dame M, Stonerock LA, Curley RW. Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs. Bioorganic & Medicinal Chemistry Letters. 17: 836-40. PMID 17112722 DOI: 10.1016/J.Bmcl.2006.10.050 | 0.572 | |||
2003 | Chapman JS, Weiss KL, Curley RW, Highland MA, Clagett-Dame M. Hydrolysis of 4-HPR to atRA occurs in vivo but is not required for retinamide-induced apoptosis. Archives of Biochemistry and Biophysics. 419: 234-43. PMID 14592467 DOI: 10.1016/J.Abb.2003.09.001 | 0.693 | |||
2001 | Abou-Issa H, Curley RW, Alshafie GA, Weiss KL, Clagett-Dame M, Chapman JS, Mershon SM. Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis. Anticancer Research. 21: 3839-44. PMID 11911255 | 0.6 | |||
2001 | Weiss KL, Alshafie G, Chapman JS, Mershon SM, Abou-Issa H, Clagett-Dame M, Curley RW. An unhydrolyzable analogue of N-(4-hydroxyphenyl)retinamide. synthesis and preliminary biological studies. Bioorganic & Medicinal Chemistry Letters. 11: 1583-6. PMID 11412986 DOI: 10.1016/S0960-894X(01)00230-X | 0.604 | |||
Show low-probability matches. |